Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

In an advisory issued Friday, Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a warning about the risk of cancer associated with alcohol ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

These targets are carefully selected based on their expression on CRC cells and minimal presence on normal tissues to reduce off-tumor toxicity. 21 Here, we discuss several key targets for CAR-T cell ...

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which ...

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

When a child develops a brain tumor, early diagnosis is essential. Alan Cohen, M.D., director of pediatric neurosurgery at Johns Hopkins Children’s Center, shares the most common signs and symptoms ...

MT-2990 is under clinical development by Mitsubishi Tanabe Pharma and currently in Phase I for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). According to GlobalData, ...